Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease
Gespeichert in:
| Titel: | Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease |
|---|---|
| Autoren: | Martinho-Grueber, Maude, Schoepfer, Alain, Maillard, Michel H, Michetti, Pierre, Brunner, Felix, Clair, Carole, Pathe Barry, Mamadou, Pittet, Valérie, von Känel, Roland, Juillerat, Pascal, Kapoglou, Ioannis, Bravo, Francisco, Sarraj, Riad, Benz, Eileen, Restellini, Sophie, Biedermann, Luc, Rogler, Gerhard, Vavricka, Stephan R |
| Weitere Verfasser: | University of Zurich, Martinho-Grueber, Maude |
| Quelle: | Eur J Gastroenterol Hepatol European journal of gastroenterology & hepatology, vol. 35, no. 1, pp. 21-30 Martinho-Grueber, Maude; Kapoglou, Ioannis; Bravo, Francisco; Sarraj, Riad; Benz, Eileen; Restellini, Sophie; Biedermann, Luc; Rogler, Gerhard; Vavricka, Stephan R; Schoepfer, Alain; Maillard, Michel H; Michetti, Pierre; Brunner, Felix; Clair, Carole; Pathe Barry, Mamadou; Pittet, Valérie; von Känel, Roland; Juillerat, Pascal (2023). Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease. European journal of gastroenterology & hepatology, 35(1), pp. 21-30. Wolters Kluwer 10.1097/MEG.0000000000002453 <http://dx.doi.org/10.1097/MEG.0000000000002453> Serveur académique lausannois Zurich Open Repository and Archive ORCID Bern Open Repository and Information System (BORIS) Datacite |
| Verlagsinformationen: | Ovid Technologies (Wolters Kluwer Health), 2022. |
| Publikationsjahr: | 2022 |
| Schlagwörter: | Male, 0301 basic medicine, 0303 health sciences, Hepatology, Alcohol Drinking, Ethanol, Gastroenterology, Original Articles: Gastroenterology, 610 Medicine & health, 2700 General Medicine, Inflammatory Bowel Diseases, 3. Good health, Cohort Studies, Humans, Cannabis, Prevalence, Alcohol Drinking/adverse effects, Alcohol Drinking/epidemiology, Inflammatory Bowel Diseases/epidemiology, Chronic Disease, 03 medical and health sciences, 10219 Clinic for Gastroenterology and Hepatology, 10057 Klinik für Konsiliarpsychiatrie und Psychosomatik, 610 Medizin und Gesundheit |
| Beschreibung: | Objectives of the study There is little guidance regarding the impact of alcohol and cannabis on the clinical course of inflammatory bowel disease. The aim of this study was to assess the prevalence, sociodemographic characteristics and impact of alcohol and cannabis use on the clinical course of the disease. Methods We performed an analysis of prospectively collected data within the Swiss Inflammatory Bowel Disease Cohort Study with yearly follow-ups and substance-specific questionnaires. We analyzed the prevalence of use, the profile of users at risk for addiction and the impact of alcohol and cannabis on the course of the disease. Results We collected data of 2828 patients included between 2006 and 2018 and analyzed it according to their completion of specific surveys on alcohol and cannabis use. The prevalence of patient-reported active use was 41.3% for alcohol and 6% for cannabis. Heavy drinkers were over-represented among retired, married smokers receiving mostly aminosalicylates and less immunosuppression. In ulcerative colitis patients, low-to-moderate drinking was associated with less extensive disease. Cannabis users were often students with ileal Crohn’s disease. Conclusion A significant proportion of patients with inflammatory bowel disease consume alcohol or cannabis. Heavy alcohol consumption is most likely in male smokers >50 years, whereas young men with ileal disease rather use cannabis. |
| Publikationsart: | Article Other literature type |
| Dateibeschreibung: | application/pdf; Alcohol_and_cannabis_consumption_in_patients_with.3.pdf - application/pdf |
| Sprache: | English |
| ISSN: | 0954-691X |
| DOI: | 10.1097/meg.0000000000002453 |
| DOI: | 10.5167/uzh-225234 |
| DOI: | 10.48350/174413 |
| Zugangs-URL: | https://pubmed.ncbi.nlm.nih.gov/36317770 https://serval.unil.ch/notice/serval:BIB_1B0BE72B83BD https://serval.unil.ch/resource/serval:BIB_1B0BE72B83BD.P001/REF.pdf http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_1B0BE72B83BD2 https://boris.unibe.ch/174413/ https://www.zora.uzh.ch/id/eprint/225234/ https://doi.org/10.5167/uzh-225234 |
| Rights: | CC BY NC ND |
| Dokumentencode: | edsair.doi.dedup.....6ec0cf5d98b3fd58c8973b5d0a83f25d |
| Datenbank: | OpenAIRE |
| Abstract: | Objectives of the study There is little guidance regarding the impact of alcohol and cannabis on the clinical course of inflammatory bowel disease. The aim of this study was to assess the prevalence, sociodemographic characteristics and impact of alcohol and cannabis use on the clinical course of the disease. Methods We performed an analysis of prospectively collected data within the Swiss Inflammatory Bowel Disease Cohort Study with yearly follow-ups and substance-specific questionnaires. We analyzed the prevalence of use, the profile of users at risk for addiction and the impact of alcohol and cannabis on the course of the disease. Results We collected data of 2828 patients included between 2006 and 2018 and analyzed it according to their completion of specific surveys on alcohol and cannabis use. The prevalence of patient-reported active use was 41.3% for alcohol and 6% for cannabis. Heavy drinkers were over-represented among retired, married smokers receiving mostly aminosalicylates and less immunosuppression. In ulcerative colitis patients, low-to-moderate drinking was associated with less extensive disease. Cannabis users were often students with ileal Crohn’s disease. Conclusion A significant proportion of patients with inflammatory bowel disease consume alcohol or cannabis. Heavy alcohol consumption is most likely in male smokers >50 years, whereas young men with ileal disease rather use cannabis. |
|---|---|
| ISSN: | 0954691X |
| DOI: | 10.1097/meg.0000000000002453 |
Full Text Finder
Nájsť tento článok vo Web of Science